Nutraceutical Excipients Market Size was valued at USD 3.7 Billion in 2022. The Nutraceutical Excipients market industry is projected to grow from USD 3.95 Billion in 2023 to USD 6.74 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.90% during the forecast period (2023 - 2032). Recent years have seen a sharp rise in the sales of nutraceutical goods, in part due to rising healthcare costs in many parts of the world are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for nutraceutical excipients is being driven by the rising urbanization. An aging population, increased urbanization, an increase in the prevalence of lifestyle-related diseases like high blood pressure, diabetes, and cardiac conditions, inadequate nutrition as a result of consumers' hectic lifestyles, and the high cost of healthcare are some of the factors that are driving the demand for nutraceuticals. The rise in incidences of osteoarthritis and diabetes is fueling the demand for dietary, food, and supplement additives. Manufacturers have adopted nutraceutical excipients due to aging populations' increased demand for dietary supplements and health problems. Nutraceuticals are goods with both nutritional and therapeutic advantages. A nutraceutical product is a substance with physiological benefits or defense against chronic sickness. Nutraceuticals can be used to boost well-being, postpone the onset of chronic diseases, extend life expectancy, or support the body's physical makeup or physiological functions. Nutraceuticals have received a lot of interest recently because of their potential to affect nutrition, safety, and therapy positively. Although pharmaceutical and nutraceutical ingredients may treat or prevent disease, only pharmaceutical ingredients have official approval. Nutraceuticals have received a lot of interest recently because of their potential to affect nutrition, safety, and therapy positively. Consumers benefit from nutritional supplements like probiotics, which include yeast and healthy bacteria since they improve digestion, gut health, immunity, nutrient absorption, and the risk of developing food allergies.
Probiotic goods come in various forms, including yogurt, drinks, and nutritional supplements in the form of pills and capsules. Pharmaceutical and dietary supplements combine to form nutraceuticals. Excipients used in nutraceuticals, commonly called "functional foods," are inert substances made with Active Pharmaceutical compounds (API) to bulk up solutions containing potent active compounds. These nutraceutical excipients are utilized in pharmaceutical-grade supplements that are standardized. The rising rise in healthcare expenses has severely impacted the market for nutraceutical excipients. Excipients are inert compounds used in the production process or contained in the dose form of nutraceutical goods but not the active ingredients. Excipients are frequently employed in pharmaceutical formulations to give solid formulations more bulk, offer long-term stability, and improve drug absorption. Additionally, it enhances the product's overall functionality and safety when in use or storage. Thus, driving the Nutraceutical Excipients market revenue.
Based on function, the Nutraceutical Excipients market segmentation includes binders, disintegrants, sweeteners, and coating agents. The binders segment dominated the market, accounting for 35% of market revenue. Since these excipients are designed to function as an adhesive to granules, "bind together" powders, and other dry ingredients to offer the necessary mechanical strength, dietary supplement producers increasingly use binders. Additionally, binders might aid in giving low-active dosage tablets more volume.
Based on the form, the Nutraceutical Excipients market segmentation includes dry and liquid. The dry segment dominated the market. Due to their simplicity and ease of handling, dry excipients are more commonly utilized than liquid excipients. The affordability and ease of the dry form in various applications can be credited to its popularity. The market for dry beverage mixes is expanding due to rising customer demand for customized blends, fortified beverages, and dry beverage mixes with extra nutrients.
The Nutraceutical Excipients market segmentation, based on type, includes probiotics & prebiotics and proteins & amino acids. The probiotics & prebiotics segment dominated the market. The benefits of probiotic-fortified foods for health, the adaptability of probiotics, and the increased use of probiotics in food due to growing consumer awareness of the need for a balanced diet are all factors driving up the demand for probiotics. The demand for probiotics in fortified meals is anticipated to remain robust due to growing consumer interest in high-end goods fortified with probiotics and increased awareness of their benefits.
The Nutraceutical Excipients market segmentation, based on Application, includes artificial and natural/organic. The natural/organic generated the most income (70.4%). The development of multifunctional excipients to take advantage of the combined benefits of bulk receivers is anticipated to assist the expansion of this market.
Figure 1: Nutraceutical Excipients Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Nutraceutical Excipients market area will dominate this market due to increased income and purchasing power, rapid middle-class population growth, increased consumer awareness of health & fitness, nutraceuticals, and increased consumer demand for nutritional & healthy products, the region's food sectors, such as, have promising prospects for growth and diversification.
Further, the major countries studied in the market report are The US, France, the UK, Italy, Spain, India, Australia, China, Canada, German, Japan, South Korea, and Brazil.
Figure 2: NUTRACEUTICAL EXCIPIENTS MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe has the second-largest market share for Nutraceutical Excipients. Since illnesses and issues are also rising due to several circumstances, the market for nutraceutical excipients is significantly influenced by the growing population. Furthermore, the German Nutraceutical Excipients market dominated, while the UK Nutraceutical Excipients market grew fastest in Europe.
From 2023 to 2032, the Asia-Pacific Nutraceutical Excipients Market will develop at the quickest CAGR. Because growing consumer spending power is one of the major factors driving demand development, consumers are becoming increasingly aware of the value of health and fitness. Additionally, owing to the globalization of foreign direct investment in the food industry, developers are establishing manufacturing facilities in the region to support the regional market's growth. Furthermore, China's Nutraceutical Excipients market had the highest market share, whereas India's Nutraceutical Excipients market was the Asia-Pacific region's fastest growing.
Nutraceutical Excipients Key Market Players & Competitive Insights
Leading market companies are extensively spending R&D on increasing their product lines, which will help the Nutraceutical Excipients market grow even more. Important market developments include new product releases, acquisitions and mergers, contractual agreements, greater investments, and collaboration with other organizations. The Nutraceutical Excipients industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate.
Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Nutraceutical Excipients industry to serve clients and expand the market sector. The Nutraceutical Excipients industry has provided some of the most important benefits recently. E.I. du Pont de Nemours & Company and other major companies in the Nutraceutical Excipients market are aiming to enhance market demand by investing in research and development activities.
E.I. du Pont de Nemours & Company is the American firm DuPont Company's full name, specializing in biotechnology, chemical and pharmaceutical manufacturing. Eleuthère Irénée du Pont (1771–1834) established the business in Delaware in 1802 to produce black powder and various explosives, the company's primary goods until the 20th century, when it started to create a wide range of chemicals. Today, DuPont produces various industrial chemicals, synthetic fibers, petroleum-based fuels and lubricants, medicines, construction materials, sterile and specialty packaging materials, cosmetics components and agricultural chemicals. It also produces building materials and products. In May 2019, DuPont signed a contract to combine its Nutrition & Biosciences division with IFF (US). According to the development details, the merged firm's valuation is USD 45.4 billion. DuPont controlled 55.4% of the shares, with IFF owning the remaining 44.6%, all ratified. This initiative is anticipated to assist the business in expanding its capacity to provide nutritious components and solutions to clients worldwide.
They are devoted to producing value for owners and customers while offering a fantastic work environment and career possibilities as a top innovation service provider in the specialty chemicals and food ingredients business. Azelis employs 3,800 people in 63 countries throughout the world. With 35,000 goods, they collaborate with around 2,300 principals to deliver creative products/services to 59,000+ clients. Their industry-specific sales teams have expert product and application expertise and business know-how, allowing us to offer value to all business partnerships. They are constantly searching for fresh talent to join their team, and they promote and support all workers' personal and professional development. In June 2020, Azelis Chemical Limited announced the acquisition of CosBond, a leading speciality chemical and food ingredient distributor in China, to strengthen its position in the market and capitalize on CosBond's present clientele.
Key Companies in the Nutraceutical Excipients market include
Cargill Corporation
Ingredion
Associated British Foods plc
JRS PHARMA
Innophos, Inc
DowDupont
Sensient Technology Corporation
Hilmar Ingredients.
Nutraceutical Excipients Industry Developments
June 2020:The relationship between IMCD and DuPont Health and Nutrition (US) has been extended. This initiative will help both businesses by enhancing their presence in Kenya, Uganda, and Egypt by providing a combined range of products to various industrial consumers.
Binders
Disintegrants
Sweetener
Coating Agent
Dry
Liquid
Probiotics & Prebiotics
Proteins & Amino Acid
Artificial
Natural/Organic
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 3.7 Billion |
| Market Size 2023 | USD 3.95 Billion |
| Market Size 2032 | USD 6.74 Billion |
| Compound Annual Growth Rate (CAGR) | 6.90% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Cargill Corporation, Ingredion, Associated British Foods plc, Kerry, Roquette Freres SA, JRS PHARMA, Innophos, Inc., DowDupont, Sensient Technology Corporation, and Hilmar Ingredients |
| Key Market Opportunities | Multifunctional Excipients Key Market |
| Key Market Dynamics | Demand For Nutraceutical Products Increasing Medical Cost Drivers Impact Analysis |
Nutraceutical Excipients Market Highlights:
Frequently Asked Questions (FAQ) :
The Nutraceutical Excipients market size was valued at USD 3.7 Billion in 2022.
The market is projected to grow at a CAGR of 6.90% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in the market are General Mills Inc., Amway, Conagra Brands Inc., Cargill Incorporated, Abbott Laboratories, Kraft Foods Group Inc., The Coca-Cola Company.
The beverage category dominated the market in 2022.
The store based had the largest share in the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
